AGP Wire

AGP

STAR Group has launched STAR Neo, a new Northern European organisation that combines STAR Translation Services Ireland and STAR Group Scandinavia.

AGP

Talentuch has broadened its pre-built Microsoft Dynamics candidate database to cover Eastern Europe, Turkey and Latin America, aiming to speed up searches for hard-to-fill Dynamics roles.

AGP

eSafe Cyber Security has formed a value-added distribution partnership with CyberLion Ltd. to bring a wider set of cybersecurity tools to Greece, Cyprus, Malta and Italy.

AGP

The market for non-invasive brain trauma monitoring devices is projected to rise from $10.73 billion in 2026 to $16.71 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company projects the next-generation oncology devices and solutions market will rise from $16.41 billion in 2025 to $19.46 billion in 2026, then nearly double again to $38.19 billion by 2030. Growth is being driven by higher…

AGP

The neurosurgical robotics market is projected to grow from $4.74 billion in 2026 to $8.04 billion by 2030, according to The Business Research Company.

AGP

The Business Research Company projects steady growth in the global neurovascular embolization devices market, driven by rising hemorrhage cases, broader use of neurointerventional procedures and stronger demand for minimally invasive stroke care….

AGP

The non-invasive ventilators market is projected to grow from $3.05 billion in 2025 to $4.42 billion by 2030, according to The Business Research Company.

AGP

The neuro-navigation systems market is projected to rise from $3.13 billion in 2025 to $4.96 billion by 2030, driven by more neurological disorders, more precise neurosurgery and wider use of imaging and AI. North America led in 2025, while…

AGP

The Business Research Company says the nerve conduit market will grow from $2.17 billion in 2026 to $2.99 billion by 2030, driven by more peripheral nerve injuries, neurological disorders and demand for regenerative repair options.

AGP

The Business Research Company projects the next generation sequencing market will grow from $16.31 billion in 2026 to $28.59 billion by 2030, driven by precision medicine, oncology diagnostics and wider genomics research.

AGP

The global market for non-PVC IV bags is projected to grow from $2.52 billion in 2026 to $3.8 billion by 2030, driven by demand for safer, more sustainable medical consumables and tighter material-safety rules.

AGP

The normothermic machine perfusion market is forecast to grow from $1.48 billion in 2025 to $3.12 billion by 2030, powered by rising transplant demand and faster preservation technology.

AGP

The Business Research Company says the next-generation in vitro diagnostics market will grow from $117.97 billion in 2025 to $188.69 billion by 2030, driven by precision medicine, genomic testing and point-of-care adoption.

AGP

The next-generation sequencing-based molecular diagnostics market is projected to expand from $2.43 billion in 2026 to $3.23 billion by 2030, according to a new report from The Business Research Company.

AGP

The Business Research Company says the global neurology monitoring market is set to grow from $7.34 billion in 2026 to $9.08 billion by 2030, fueled by more complex neurological surgeries, rising traumatic brain injuries and wider use of…

AGP

The market for non-invasive cholesterol readers is projected to rise from $1.3 billion in 2025 to $2.63 billion by 2030, driven by cardiovascular disease prevalence, healthcare spending and demand for painless testing.

AGP

The global neurorehabilitation devices market is projected to grow from $2.07 billion in 2025 to $3.58 billion by 2030, driven by rising neurological disorders, aging populations and demand for home-based recovery.

AGP

The global neurostimulation devices market is projected to grow from $6.86 billion in 2025 to $7.64 billion in 2026, as demand rises for treatments for chronic neurological conditions and pain.

AGP

The market for neurology diagnostic and monitoring devices is projected to rise from $9.32 billion in 2025 to $10.19 billion in 2026, with growth tied to aging populations, rising neurological disease rates and better imaging tools.